Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's (BOUT) last reported annual revenue was N/A.
Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's (BOUT) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) is not profitable as of its last reported annual financials.
The net profit margin for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its laster reported year is N/A
The return on equity (ROE) for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its last reported annual financials is : N/A
The return on assets (ROA) for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its last reported annual financials is : 0.00%
The dividend yield for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) from its laster reported year is 1.21%
Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's(BOUT) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BOUT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
